Showing results (501-510 of 513) with videos related to
Sort By:
Pageof 52
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 22, 2023
CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell TumorsIngo Hartlapp, Philipp E Hartrampf, Sebastian E Serfling, et al.Oncogene|November 29, 2023
PRAME induces genomic instability in uveal melanomaStefan Kurtenbach, Margaret I Sanchez, Jeffim Kuznetsoff, et al.Journal of Inorganic Biochemistry|December 16, 2004
Neuroglobin and cytoglobin in search of their role in the vertebrate globin familyThomas Hankeln, Bettina Ebner, Christine Fuchs, et al.BMC Public Health|January 18, 2006
Prediction of depression in European general practice attendees: the PREDICT studyMichael King, Scott Weich, Francisco Torres-González, et al.Archives of General Psychiatry|December 3, 2008
Development and validation of an international risk prediction algorithm for episodes of major depression in general practice attendees: the PredictD studyMichael King, Carl Walker, Gus Levy, et al.Nature Medicine|August 12, 2009
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growthRomulo J C Albuquerque, Takahiko Hayashi, Won Gil Cho, et al.The American Journal of Gastroenterology|March 13, 2025
International, Multicenter Analysis of Endoscopic Full-Thickness Resection of Duodenal Neuroendocrine TumorsAndreas Wannhoff, Zaheer Nabi, Leon M G Moons, et al.JHEP Reports : Innovation in Hepatology|May 27, 2024
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic eventsNajib Ben Khaled, Marie Möller, Leonie S Jochheim, et al.Pilot and Feasibility Studies|February 17, 2024
Supporting physical activity through co-production in people with severe mental ill health (SPACES): protocol for a randomised controlled feasibility trialGareth Jones, Laura Bailey, Rebecca J Beeken, et al.Journal for Immunotherapy of Cancer|May 9, 2024
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapyChristopher Lischer, Martin Eberhardt, Cindy Flamann, et al.Pageof 52